sexual dysfunction program (GeneOne Life Science/Theragen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesexual dysfunction program (GeneOne Life Science/Theragen)
Drug Alias Namesexual dysfunction program (VGX International/Theragen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSexual Dysfunction, Physiological
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeneone Life Science Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeneone Life Science Inc
Active IndicationsN/A
Inactive IndicationsSexual Dysfunction, Physiological

Other Information

ATC CodeN/A
Related LinksN/A